Jun. 11, 2015News & Opinions
Bayer HealthCare said it has entered a definitive agreement to sell its Diabetes Care business with sales in 2014 of €909 million to Panasonic Healthcare Holdings for €1.02 billion.
Apr. 16, 2015News & Opinions
Bayer HealthCare has announced plans to invest $100 million in a product testing facility at its Berkeley, California, US manufacturing site to support the next generation of treatments for patients with hemophilia A.
Mar. 12, 2015News & Opinions
Bayer aims to achieve strong sales and earnings growth for its life science businesses in the coming years, CEO Marijn Dekkers said at the "Meet Management" investor conference in Berlin, Germany.
Mar. 02, 2015News & Opinions
Bayer managing board member Werner Bauman, recently named to head the HealthCare sub-group, has vowed to fight for the independence of Germany's largest drugmaker after the carve-out of its plastics unit.
Feb. 26, 2015News & Opinions
Richard Pott, until 2013 Bayer group managing board with responsibility for Strategy and Human Resources along with the regions Americas, Africa and Middle East, has been approved by the supervisory board of the group's holding to stand ...
Feb. 19, 2015News & Opinions
As the search narrows for a successor to Chris Viehbacher, who was dismissed last year as CEO of French drugmaker Sanofi, French newspaper Le Figaro has identified Bayer HealthCare head Oliver Brandicourt as the most likely candidate.
Jan. 12, 2015News & Opinions
Bayer HealthCare's Gadavist (gadobutrol) injection contrast medium has been approved by the US Food and Drug Administration for use with magnetic resonance imaging (MRI) in pediatric patients less than two years of age, including newborns ...
Sep. 15, 2014News & Opinions
Bayer HealthCare has completed the sale of its interventional device business to Boston Scientific for $ 415 million.
Sep. 01, 2014News & Opinions
German neurologists are standing by currently prescribed interferon-based multiple sclerosis treatments, despite a warning issued by the Federal Institute for Drugs and Medical Devices, BfArM.
Jul. 04, 2014News & Opinions
Bayer HealthCare said it plans to keep consumer brands such as Dr. Scholl's and Coppertone it picked up in its $14 billion buy of US Merck's non-prescription drugs business in May.
The latest information directly via newsletter.